Impaired DNA repair and genomic stability in hereditary tyrosinemia type 1

被引:5
|
作者
van Dyk, E. [1 ]
Pretorius, P. J. [1 ]
机构
[1] North West Univ, Ctr Human Metabon, Sch Phys & Chem Sci, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
Hereditary tyrosinemia; Microsatellite instability; Gene expression; Genetic instability; Hepatocellular carcinoma; MESSENGER-RNA LEVELS; MICROSATELLITE INSTABILITY; EXCISION-REPAIR; MURINE MODEL; FUMARYLACETOACETATE; CANCER; LIVER; EXPRESSION; DAMAGE; STRESS;
D O I
10.1016/j.gene.2011.12.021
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The autosomal recessive disorder, hereditary tyrosinemia type 1 (HT1), is caused by a defective fumarylacetoacetate hydrolase enzyme. Consequently intermediate metabolites such as fumarylacetoacetate, succinylacetone and p-hydroxyphenylpyruvic acid accumulate. Characteristic to HT1 is the development of hepatocellular carcinoma, irrespective of dietary intervention or pharmacological treatment. Carcinogenesis may occur through a chromosomal instability mutator phenotype or a microsatellite instability phenotype, and deficient DNA repair may be a contributing factor thereof. The purpose of this study was to investigate the expression of DNA repair proteins, and the possible occurrence of microsatellite instability in HT1. Gene expression analyses show low expression of hOGG1 and ERCC1 in HT1 patient lymphocytes. Results from microsatellite instability analyses show allelic imbalance on chromosome 7 of the fah(-/-) mouse genome, and instability of the 025123, D5S346 and (possibly) D17S250 microsatellite markers, in HT1 patient lymphocytes. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 50 条
  • [1] Hereditary tyrosinemia type 1: Impairment of DNA repair by characteristic metabolites
    Van Dyk, E.
    Bhabha, H.
    Pretorius, P. J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 23 - 23
  • [2] Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways
    van Dyk, E.
    Steenkamp, A.
    Koekemoer, G.
    Pretorius, P. J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (01) : 32 - 36
  • [3] Detection of hereditary tyrosinemia type 1 (HT1) by restriction analysis of PCR amplified genomic DNA.
    Schranz, DB
    Jack, R
    Scott, CR
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (02) : 294 - 294
  • [4] Hereditary Tyrosinemia Type 1 in Turkey
    Cigdem Aktuglu-Zeybek, Ayse
    Kiykim, Ertugrul
    Cansever, M. Serif
    HEREDITARY TYROSINEMIA: PATHOGENESIS, SCREENING AND MANAGEMENT, 2017, 959 : 157 - 172
  • [6] Goldenhar syndrome and hereditary tyrosinemia type 1
    Al-Sayed, MA
    Al-Asmari, AM
    Rashed, MS
    SAUDI MEDICAL JOURNAL, 2002, 23 (12) : 1527 - 1531
  • [7] Type I hereditary tyrosinemia: from tyrosine to DNA replication
    Laval, F
    M S-MEDECINE SCIENCES, 1999, 15 (05): : 706 - 708
  • [8] Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1
    Morrow, Genevieve
    Tanguay, Robert M.
    HEREDITARY TYROSINEMIA: PATHOGENESIS, SCREENING AND MANAGEMENT, 2017, 959 : 9 - 21
  • [9] The outcome of seven patients with hereditary tyrosinemia type 1
    Gokay, Songul
    Ustkoyuncu, Pembe Soylu
    Kardas, Fatih
    Kendirci, Mustafa
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (10): : 1151 - 1157
  • [10] Simple detection of a (Finnish) hereditary tyrosinemia type 1 mutation
    StLouis, M
    Poudrier, J
    Tanguay, RM
    HUMAN MUTATION, 1996, 7 (04) : 379 - 380